A multicenter randomized controlled trial comparing short- and medium-term outcomes of novel biologics and lightweight synthetic mesh for laparoscopic inguinal hernia repair.

MLA

Xue, P., et al. “A Multicenter Randomized Controlled Trial Comparing Short- and Medium-Term Outcomes of Novel Biologics and Lightweight Synthetic Mesh for Laparoscopic Inguinal Hernia Repair.” Hernia : The Journal of Hernias and Abdominal Wall Surgery, vol. 28, no. 4, Aug. 2024, pp. 1337–44. EBSCOhost, https://doi.org/10.1007/s10029-024-03046-4.

APA

Xue, P., Yue, F., Li, S., Cheng, W., Zhou, H., Yan, W., Zhou, Y., Tang, J., Li, J., & Zhang, J. (2024). A multicenter randomized controlled trial comparing short- and medium-term outcomes of novel biologics and lightweight synthetic mesh for laparoscopic inguinal hernia repair. Hernia : The Journal of Hernias and Abdominal Wall Surgery, 28(4), 1337–1344. https://doi.org/10.1007/s10029-024-03046-4

Chicago

Xue, P, F Yue, S Li, W Cheng, H Zhou, W Yan, Y Zhou, J Tang, J Li, and J Zhang. 2024. “A Multicenter Randomized Controlled Trial Comparing Short- and Medium-Term Outcomes of Novel Biologics and Lightweight Synthetic Mesh for Laparoscopic Inguinal Hernia Repair.” Hernia : The Journal of Hernias and Abdominal Wall Surgery 28 (4): 1337–44. doi:10.1007/s10029-024-03046-4.